Glenmark Pharma is set to declare its results for the quarter ended June 2012 on Thursday. Analysts on an average expect the profit after tax to fall by 37.62% year-on-year and 13.8% quarter-on-quarter to Rs 131 crore during the quarter.
first published: Aug 2, 2012 08:08 am
A collection of the most-viewed Moneycontrol videos.

Point-to-Point vs Rolling Returns for Mutual Funds: Full Breakdown

From Hesitant Heir to Undisputed Leader: Sanjiv Bajaj's Leadership Story

Nifty Fails To Defend 26,000 Amid Sluggish Start To Final Week Of 2025| Closing Bell Live

Nifty Aims To Defend 26,000 Amid Thin Volumes, Record-Low VIX| Opening Bell Live
You are already a Moneycontrol Pro user.

